Reem Elajez
Reem Elajez publishes mostly in Infectious Diseases, Geriatrics and Gerontology and Pharmacology, on topics such as Pharmaceutical Practices and Patient Outcomes, Antibiotic Use and Resistance and COVID-19 Clinical Research Studies.
- World rank
- #4,743,006 of 7,710,434 ranked researchers
- Rank in Qatar
- #2,504 of 3,423
- Works
- 33
- Citations
- 265
- Citations per work
- 8.0
What does Reem Elajez research?
Reem Elajez's work is mostly in Medicine (36%), Immunology and Microbiology (7%), Pharmacology, Toxicology and Pharmaceutics (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1752.7%
- Health Sciences1236.3%
- Medicine1236.3%
- Life Sciences411.0%
- 1Infectious Diseases13% of their works
- 2Geriatrics and Gerontology8% of their works
- 3Pharmacology8% of their works
- 4Epidemiology8% of their works
- 5Applied Microbiology and Biotechnology7% of their works
- 6Toxicology4% of their works
Research topics
- Pharmaceutical Practices and Patient Outcomes
- Antibiotic Use and Resistance
- COVID-19 Clinical Research Studies
- Pharmacovigilance and Adverse Drug Reactions
- Drug-Induced Adverse Reactions
- Antibiotic Resistance in Bacteria
- Immunodeficiency and Autoimmune Disorders
- Pneumocystis jirovecii pneumonia detection and treatment
Which keywords describe Reem Elajez's research?
The keywords of their largest research topics: Epidemiology, Antibiotic Resistance, Inappropriate Medication Use, Polypharmacy, Antimicrobial Stewardship, Global Health, Clinical Characteristics and SARS-CoV-2.
- Primary Immunodeficiency
- Pneumocystis
- Genetic Mutations
- Stevens-Johnson Syndrome
- HLA-B*5701
- SARS-CoV-2
- Global Health
- Polypharmacy
- Antibiotic Resistance
- Epidemiology
- Inappropriate Medication Use
- Antimicrobial Stewardship
- Clinical Characteristics
- Adverse Drug Reactions
- Pharmacovigilance
- ESKAPE Pathogens
- Multidrug-Resistant Bacteria
- Pneumonia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Epidemiology143 topics
- Antibiotic Resistance92 topics
- Inappropriate Medication Use71 topic
- Polypharmacy71 topic
- Antimicrobial Stewardship61 topic
- Global Health61 topic
- Clinical Characteristics51 topic
- SARS-CoV-251 topic
- Adverse Drug Reactions41 topic
- HLA-B*570141 topic
- Pharmacovigilance41 topic
- Stevens-Johnson Syndrome41 topic
- ESKAPE Pathogens31 topic
- Genetic Mutations31 topic
- Multidrug-Resistant Bacteria31 topic
- Pneumocystis31 topic
- Pneumonia31 topic
- Primary Immunodeficiency31 topic
Where does Reem Elajez work?
Reem Elajez's main affiliation in the publication record is Hamad Medical Corporation, Qatar.
How many publications and citations does Reem Elajez have?
OpenAlex counts 33 works and 265 citations for Reem Elajez, an h-index of 8, ranking #4,743,006 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Reem Elajez. Posts are plain text and can be reported.